CRISPR creates new crop from wild weeds, and base editing achieves remission in leukemia patients
This week brought major CRISPR breakthroughs spanning agriculture and medicineβfrom transforming weedy plants into profitable crops to achieving complete remission in cancer patients.
π± Scientists turn wild weeds into profitable crops using CRISPR
Researchers used CRISPR-Cas9 to domesticate field pennycress, a freeze-tolerant wild plant, creating a new oilseed crop that can grow between traditional farming seasons.
The team reduced seed glucosinolate content by 75% by targeting specific transcription factors, making the crop suitable for food and fuel production
CRISPR modifications created "double-low" canola-like seed compositions with low erucic acid and reduced fiber content while maintaining high yields
Knockout of the TT8 gene reduced seed dormancy and weediness, preventing the modified plants from becoming invasive in fields
Why it matters: This approach offers farmers three cash crops in two years instead of leaving land fallow, providing cover crop benefits while producing renewable fuel feedstock.
Key Findings
π©Ί Base editing achieves 100% remission in leukemia trial
All 11 patients with T-cell acute lymphoblastic leukemia achieved complete morphogenic remission after 28 days of treatment with base-edited CAR-T cells
82% of patients underwent stem-cell transplantation and 64% remain in remission 3 to 36 months after treatment
The base editing strategy engineered CAR-T cells to remain invisible to antibody drugs while maintaining their cancer-fighting ability
π§ CRISPR screen identifies new Alzheimer's drug targets
Researchers used genome-wide CRISPR screening to identify CHD1 and MAP3K7 genes as mediators of cancer immunotherapy resistance
Loss of these genes potentiated the transcriptional response to interferon-gamma, making cancer cells more vulnerable to tumor-reactive T cells
Immune checkpoint blockade was more effective in mouse models deficient in these genes, with elevated CD8+ T cell numbers and activation
π¬ Anti-CRISPR protein reveals new genome editing insights
Scientists discovered that bacteriophage protein AcrIIA27 blocks CRISPR-Cas9 by binding to the guide RNA's exposed regions
This mechanism suggested that similar exposed regions in guide RNAs might compromise editing efficiency in general
Truncating these problematic regions in different editing systems significantly enhanced genome-editing efficiency in human cells
π― Enhanced Cas9 systems create larger gene deletions in plants
Researchers developed MND-Cas9 systems that produced substantially larger deletions without reducing editing efficiency in rice
The enhanced systems successfully knocked out microRNA genes, producing larger seeds, and modified gene regulatory regions
MND-Cas9v2 with DNA-binding domains achieved both higher efficiency and larger deletion sizes compared to standard Cas9
𧬠Light-controlled CRISPR targets mitochondrial DNA mutations
Scientists created a near-infrared light-activated CRISPR system that can detect and edit mitochondrial DNA mutations with spatial precision
The system achieved a detection limit of 0.83 pM for mtDNA mutations and enabled controlled imaging in living cells and tumor-bearing mice
Light activation triggered DNA editing that disrupted mitochondrial function and promoted cancer cell death, resulting in effective tumor suppression
π¬ CRISPR screen reveals gene networks controlling brain cell fate
Single-cell CRISPR screening of 44 transcription factors in human brain organoids identified new regulators of cortical development
ZNF219 (previously uncharacterized) repressed neural differentiation while NR2E1 and ARX had opposing roles in brain cell lineage progression
The study revealed conserved mechanisms of brain stem cell plasticity across primates and identified genes linked to neurodevelopmental disorders
Implications
These studies showcase CRISPR's expanding reach from creating new agricultural crops to treating cancer and understanding brain development. The convergence of precision editing, light control, and systematic screening approaches suggests we're entering an era where genetic tools can be tailored for increasingly specific applications across biology and medicine.
Studies in this issue
Primary sources used for this newsletter.
- Base Editing May Improve CAR T-cell Therapymain storyCancer discovery2026-01-23PMID 41575289
- Improved Cas9 gene editing tools increase multiple DNA deletions and target more sites in plantskey findingJournal of integrative plant biology2026-01-22PMID 41566884
- Gene editing screens under immune pressure identify CHD1 and MAP3K7 as factors linked to cancer immunotherapy resistancekey findingCell reports. Medicine2026-01-21PMID 41564866
- Developing pennycress as a new oilseed crop by combining important domestication traits using gene editingkey findingNature plants2026-01-23PMID 41578087
- Understanding the Gene Networks That Control Human Brain Cell Developmentkey findingNature2026-01-21PMID 41565813
- CRISPR screen finds NEK6 affects how endometrial cancer responds to CDK4/6 inhibitorskey findingFrontiers in pharmacology2026-01-21PMID 41560755
- Highly sensitive DNA detection using a dual-blocking CRISPR system without amplification and low false signalskey findingbioRxiv : the preprint server for biology2026-01-23PMID 41573851
Continue reading
All CRISPR Gene Editing issuesGet the next CRISPR Gene Editing issue
Seven papers, once a week. Free.